Search

everythinglearnresearchcommunity

for

Search:↓

RXRα is crucial for proper immune response and links diet to immune function.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

Human dermal γδT-cells respond to stress in hair follicles, contributing to hair loss.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

Targeting Vδ1+T-cells may help treat alopecia areata.

Immune cells in Hidradenitis suppurativa become more inflammatory and may be important for treatment targets.

The protein p53 directly reduces the production of Keratin 17, a skin and hair protein, in rats with radiation dermatitis.

TLR4 is important in aging-related diseases and could be a new treatment target.

Oxidative stress plays a significant role in alopecia areata, and new treatments may include JAK inhibitors and antioxidants.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Argan press cake extract might help grow hair and protect hair cells from damage and inflammation.

Certain IL-18 gene variations may increase the risk of alopecia areata.

Excessive sun protection might cause frontal fibrosing alopecia by disrupting skin immune balance.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

The treatment might help COVID-19 related hair loss, but more research is needed.

PRP can help regrow hair in people with alopecia.

Skin can produce blood cells, often due to disease, which might lead to new treatments for skin and blood conditions.

Keratin treatment reduces astrocyte reactivity and inflammation.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Higher levels of CCL7 are linked to more severe hair loss in alopecia areata patients.

Low-dose naltrexone might be a cheap and effective additional treatment for hair loss with scalp discomfort due to its anti-inflammatory effects and few side effects.

The symposium concluded that a specific lipid might cause hair loss, inflammation is a key factor, and stem cells in bald scalps aren't working right, suggesting new treatment targets.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Itraconazole effectively treated a woman's painful skin condition and hair loss.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.